# Probiotic Yogurt Supplement in Reducing Diarrhea in Patients With Metastatic Kidney Cancer Being Treated With Vascular Endothelial Growth Factor-Tyrosine Kinase Inhibitor

> **NCT02944617** · NA · COMPLETED · sponsor: **City of Hope Medical Center** · enrollment: 21 (actual)

## Conditions studied

- Diarrhea
- Metastatic Renal Cell Carcinoma
- Stage IV Renal Cell Cancer

## Interventions

- **OTHER:** Laboratory Biomarker Analysis
- **DIETARY_SUPPLEMENT:** Micronutrient-Fortified Probiotic Yogurt
- **DRUG:** VEGF-TKI

## Key facts

- **NCT ID:** NCT02944617
- **Lead sponsor:** City of Hope Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-11-11
- **Primary completion:** 2021-12-19
- **Final completion:** 2021-12-19
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2024-02-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02944617

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02944617, "Probiotic Yogurt Supplement in Reducing Diarrhea in Patients With Metastatic Kidney Cancer Being Treated With Vascular Endothelial Growth Factor-Tyrosine Kinase Inhibitor". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02944617. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*